Regulation of cell cycle progression by ganglioside-a novel strategy against malignant glioma
Regulation of cell cycle progression by ganglioside-a novel strategy against malignant glioma
批准号:
13671434
负责人:
IZUMOTO Shuichi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
为了研究神经节苷脂是否调节神经胶质瘤细胞的生长,将最简单的神经节苷脂GM3通过枕大池注入神经胶质瘤细胞培养和荷瘤大鼠体内。(1)用GM3培养4株原代胶质瘤细胞和4株胶质瘤细胞。四甲基偶氮唑盐比色法显示,浓度为20~200微摩尔的GM3对胶质瘤细胞的增殖有抑制作用(P<;0.05)。抑制作用依赖于GM3的浓度。(2)将C6胶质瘤细胞接种于大鼠脑膜腔内,建立可用于体内分析的大鼠胶质瘤模型。GM3治疗组(n=20)在胶质瘤细胞接种后10d存活22.0天,对照组(n=15)存活19.5天(P<;0.05)。GM3给药大鼠未检测到急性毒性。(3)TUNEL法病理检查发现,GM3可诱导胶质瘤细胞发生凋亡。GM3给药后1~3d,大鼠脑内可检测到凋亡细胞,且仅见于胶质瘤细胞团的表面。为了探讨GM3是否对胶质瘤细胞的侵袭有干扰作用,采用Boyden小室实验和切片培养模型侵袭实验。(4)GM3抑制胶质瘤细胞的运动和侵袭,其作用依赖于GM3的浓度。局部应用GM3作为控制胶质瘤的一种新策略,可能是一种有效和安全的方法。
英文摘要
To investigate whether gangliosides modulate the progression of glioma cells, GM3, the simplest ganglioside, was administered into the culture of glioma cells and into the glioma-bearing rats via the cistema magna. (1) Four primary glioma cells and 4 glioma cell lines were cultured with GM3. MTT assay demonstrated that the glioma pells were inhibited those proliferation by GM3 with the concentration of 20 to 200 micromole(P<0.05). The inhibition was dependent on the concentration of GM3. (2) Rat glioma model for the in vivo analysis was made by the inoculation of C6 glioma cells into the rat meningeal space. Treated rats (n=20), those were administered GM3 on 10 days after glioma-cell-inoculation, survived 22.0 days, whereas the control rats(n=15) survived 19.5 days(P<0.05). Acute toxicity was not detected on the rats after GM3 administration. (3) On the pathological examination by TUNEL method,GM3 was found to induce apoptosis on the glioma cells. The apoptotic cells were detected from 1 to 3 days after administration of GM3 in the rat brain and detected only on the surface of the mass of glioma cells. Those results demonstrated that GM3 does not infiltrate well into the brain or into the mass of glioma cells.To investigate whether GM3 interfere with the invasion of the glioma cells, Boyden chamber assay and invasion assay with slice culture model were performed.(4) As a result, glioma cells were inhibited its motility and invasion by GM3, that was dependent on the concentration of GM3.These results demonstrate that GM3 inhibits both the proliferation and invasion of glioma cells. The local administration of GM3 as a new strategy for the control of glioma may be a useful and safe method.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shuichi Izumoto: "PTEN mutations in malignant gliomas asnd their relation with meningeal gliomatosis"Journal of Neuro-Oncology. 53. 21-26 (2001)
Shuichi Izumoto:“恶性神经胶质瘤中的 PTEN 突变及其与脑膜神经胶质瘤病的关系”神经肿瘤学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yuji Nakatsuji: "Selective cell-cycle arrest and induction of apotosis in proliferating neural cells by ganglioside GM3"Experimental Neurology. 168. 290-299 (2001)
Yuji Nakatsuji:“神经节苷脂 GM3 选择性细胞周期停滞和增殖神经细胞凋亡诱导”实验神经病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Manabu Kinoshita: "Primary malignant lymphoma of the tritgeminal region treated with rapid infusion of high-dose MTX and radiation case report and review of the literature"Surgical Neurology. in press. (2003)
Manabu Kinoshita:“快速输注大剂量MTX和放射治疗三叉神经区原发性恶性淋巴瘤病例报告及文献综述”外科神经病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
泉本修一: "ラトケ_胞の手術治療選択と長期成績"日本内分泌学会雑誌. 78. 66-69 (2002)
Shuichi Izumimoto:“Radke 囊肿的手术治疗选择和长期结果”日本内分泌学会杂志 78. 66-69 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Jamshidi Jamshid: "Central neurocytoma presenting with intratumoral hemorrhage"Neurosurgical Review. 24. 48-52 (2001)
Jamshidi Jamshid:“伴有瘤内出血的中枢神经细胞瘤”神经外科评论。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Investigation of the immunotherapy targeting WT1 against grade 2/3 glioma and its promoting and inhibiting mechanism in the brain.
-
批准号:17K10881
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:IZUMOTO Shuichi
-
依托单位:
Combined WT1 vaccine immunotherapy and targeted chemotherapy against metastatic brain tumor
-
批准号:26462195
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2014
-
负责人:IZUMOTO Shuichi
-
依托单位:
Investigation of the immunotherapy targeting WT1 combined with chemotherapy against newly diagnosed malignant glioma.
-
批准号:20390384
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.65万
-
财政年份:2008
-
负责人:IZUMOTO Shuichi
-
依托单位:
Induction and characterization of WT1-specific Th1-type CD4(+) T cells to develop WT1 immunotherapy against malignant gliomas.
-
批准号:19659366
-
项目类别:Grant-in-Aid for Exploratory Research
-
资助金额:$1.98万
-
财政年份:2007
-
负责人:IZUMOTO Shuichi
-
依托单位:
Development of blood-brain barrier permeable TAT chimera Interferon-β for the treatment of malignant gliomas.
-
批准号:17591511
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2005
-
负责人:IZUMOTO Shuichi
-
依托单位:
Inhibition of glioma cell proliferation and invasion by neural stem cell factor and ex vivo gene therapy.
-
批准号:15591521
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:IZUMOTO Shuichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
GM3作为去势抵抗性前列腺癌(CRPC)生物标志物的机制研究及其在CRPC早期诊疗中的应用探索
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:林锷
-
依托单位:
神经节苷脂GM3种间差异调控宿主对甲肝病毒敏感性的作用机制研究
-
批准号:82372238
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:冯辉
-
依托单位:
神经节苷脂GM3介导的谷氨酰胺转运障碍在糖尿病肾病足细胞损伤中的作用及机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:杨倩
-
依托单位:
神经节苷脂GM3促进代谢相关脂肪性肝病发生及其机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:叶正芹
-
依托单位:
LncRNA DLGAP1-AS2/FAM3D/GM3调控轴介导食管鳞癌化疗耐药的机制研究
-
批准号:82172590
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:周爱萍
-
依托单位:
神经节苷脂GM3对低密度脂蛋白氧化和单核-巨噬细胞行为的影响及其分子机制
-
批准号:81560083
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:陈勇
-
依托单位:
作为治疗性肿瘤疫苗N-修饰GM3抗原的全合成及免疫活性研究
-
批准号:21202200
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2012
-
负责人:俞世冲
-
依托单位:
基于糖抗原STn和GM3的抗肿瘤疫苗研究
-
批准号:81172916
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2011
-
负责人:叶新山
-
依托单位:
N苯乙酰-GM3连接的新型抗黑色素瘤糖多肽疫苗研究
-
批准号:30901373
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2009
-
负责人:冯皓
-
依托单位:
神经节苷脂GM3复合物的合成与抗肿瘤活性研究
-
批准号:20502002
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2005
-
负责人:邢国文
-
依托单位: